Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Terminated 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 2NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 5Squamous Intraepithelial Lesions 2Papillomavirus Infections 2Leukemia, Myeloid, Acute 2HIV Infections 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Anus Neoplasms 2Solitary Fibrous Tumor, Pleural 1Smoldering Multiple Myeloma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Prostate Adenocarcinoma 1Precancerous Conditions 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Mouth Neoplasms 1Mesothelioma, Malignant 1Melanoma 1Malignant mesenchymal tumor 1Lung Neoplasms 1Liposarcoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leiomyosarcoma 1

Interventions

Prednisone 112Docetaxel 87Leuprolide 79enzalutamide 72Abiraterone Acetate 67bicalutamide 53Goserelin 50acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 42Radiotherapy 39abiraterone 28Magnetic Resonance Spectroscopy 27Gonadotropin-Releasing Hormone 24gallium 68 PSMA-11 23apalutamide 22Androgen Antagonists 22luprolide acetate gel depot 21sipuleucel-T 20Radiosurgery 20Triptorelin Pamoate 18cabazitaxel 17cabozantinib 16Radiotherapy, Intensity-Modulated 16Flutamide 16pembrolizumab 15radium Ra 223 dichloride 14Prednisolone 14Nivolumab 14Dutasteride 14Dexamethasone 14Radiation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × Prostatic Neoplasms × Watchful Waiting × Clear all
NCT01251861 2026-05-29

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
108 enrolled 16 charts
Genitourinary

Prostatic Neoplasms

NCT02799745 2024-12-06

ENACT

Astellas Pharma Inc

Phase 2 Completed
227 enrolled 24 charts
Genitourinary

Prostatic Neoplasms

NCT01928485 2020-10-22

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Case Comprehensive Cancer Center

Phase 2 Terminated
6 enrolled 23 charts
Genitourinary

Prostatic Neoplasms

NCT00084864 2017-06-12

Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate

Roswell Park Cancer Institute

Phase 2 Terminated
25 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT00002651 2017-04-17

SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

SWOG Cancer Research Network

Phase 3 Completed
3,040 enrolled 16 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡